{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T13:27:04Z","timestamp":1773840424351,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-025-02704-6","type":"journal-article","created":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T21:22:41Z","timestamp":1744233761000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["MIS18BP1 promotes bladder cancer cell proliferation and growth via inactivating P53 signaling pathway"],"prefix":"10.1007","volume":"42","author":[{"given":"WenJing","family":"Cao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XueYing","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuze","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YuLin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YuQing","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ZongLiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JiangShui","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"WeiQing","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,9]]},"reference":[{"key":"2704_CR1","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1007\/s00345-019-02984-4","volume":"38","author":"A Richters","year":"2020","unstructured":"Richters A, Aben KKH, Kiemeney L. The global burden of urinary bladder cancer: an update. World J Urol. 2020;38:1895\u2013904. https:\/\/doi.org\/10.1007\/s00345-019-02984-4.","journal-title":"World J Urol"},{"key":"2704_CR2","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.eururo.2016.06.020","volume":"71","author":"J Alfred Witjes","year":"2017","unstructured":"Alfred Witjes J, Lebret T, Comp\u00e9rat EM, Cowan NC, De Santis M, Bruins HM, et al. Updated 2016 EAU guidelines on muscle-invasive and metastatic bladder cancer. Eur Urol. 2017;71:462\u201375. https:\/\/doi.org\/10.1016\/j.eururo.2016.06.020.","journal-title":"Eur Urol"},{"key":"2704_CR3","doi-asserted-by":"publisher","first-page":"4602","DOI":"10.1200\/jco.2005.07.757","volume":"23","author":"H Von Der Maase","year":"2005","unstructured":"Von Der Maase H, Sengelov L, Roberts JT, Ricci S, Dogliotti L, Oliver T, et al. Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer. J Clin Oncol. 2005;23:4602\u20138. https:\/\/doi.org\/10.1200\/jco.2005.07.757.","journal-title":"J Clin Oncol"},{"key":"2704_CR4","doi-asserted-by":"publisher","first-page":"17022","DOI":"10.1038\/nrdp.2017.22","volume":"3","author":"O Sanli","year":"2017","unstructured":"Sanli O, Dobruch J, Knowles MA, Burger M, Alemozaffar M, Nielsen ME, et al. Bladder cancer. Nat Rev Dis Primers. 2017;3:17022. https:\/\/doi.org\/10.1038\/nrdp.2017.22.","journal-title":"Nat Rev Dis Primers"},{"key":"2704_CR5","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41572-023-00468-9","volume":"9","author":"L Dyrskj\u00f8t","year":"2023","unstructured":"Dyrskj\u00f8t L, Hansel DE, Efstathiou JA, Knowles MA, Galsky MD, Teoh J, et al. Bladder cancer. Nat Rev Dis Primers. 2023;9:58. https:\/\/doi.org\/10.1038\/s41572-023-00468-9.","journal-title":"Nat Rev Dis Primers"},{"key":"2704_CR6","doi-asserted-by":"publisher","first-page":"140043","DOI":"10.1098\/rsob.140043","volume":"4","author":"L Subramanian","year":"2014","unstructured":"Subramanian L, Toda NR, Rappsilber J, Allshire RC. Eic1 links Mis18 with the CCAN\/Mis6\/Ctf19 complex to promote CENP-A assembly. Open Biol. 2014;4:140043. https:\/\/doi.org\/10.1098\/rsob.140043.","journal-title":"Open Biol"},{"key":"2704_CR7","doi-asserted-by":"publisher","first-page":"894","DOI":"10.15252\/embr.201643564","volume":"18","author":"F Spiller","year":"2017","unstructured":"Spiller F, Medina-Pritchard B, Abad MA, Wear MA, Molina O, Earnshaw WC, et al. Molecular basis for Cdk1-regulated timing of Mis18 complex assembly and CENP-A deposition. EMBO Rep. 2017;18:894\u2013905. https:\/\/doi.org\/10.15252\/embr.201643564.","journal-title":"EMBO Rep"},{"key":"2704_CR8","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.cell.2014.06.016","volume":"158","author":"KL Mckinley","year":"2014","unstructured":"Mckinley KL, Cheeseman IM. Polo-like kinase 1 licenses CENP-A deposition at centromeres. Cell. 2014;158:397\u2013411. https:\/\/doi.org\/10.1016\/j.cell.2014.06.016.","journal-title":"Cell"},{"key":"2704_CR9","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.devcel.2016.05.006","volume":"37","author":"J Ohzeki","year":"2016","unstructured":"Ohzeki J, Shono N, Otake K, Martins NM, Kugou K, Kimura H, et al. KAT7\/HBO1\/MYST2 Regulates CENP-A chromatin assembly by antagonizing Suv39h1-mediated centromere inactivation. Dev Cell. 2016;37:413\u201327. https:\/\/doi.org\/10.1016\/j.devcel.2016.05.006.","journal-title":"Dev Cell"},{"key":"2704_CR10","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1111\/bph.15422","volume":"178","author":"SY Sun","year":"2021","unstructured":"Sun SY, Hu XT, Yu XF, Zhang YY, Liu XH, Liu YH, et al. Nuclear translocation of ATG5 induces DNA mismatch repair deficiency (MMR-D)\/microsatellite instability (MSI) via interacting with Mis18\u03b1 in colorectal cancer. Br J Pharmacol. 2021;178:2351\u201369. https:\/\/doi.org\/10.1111\/bph.15422.","journal-title":"Br J Pharmacol"},{"key":"2704_CR11","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.omto.2020.04.002","volume":"17","author":"SK Saha","year":"2020","unstructured":"Saha SK, Choi HY, Yang GM, Biswas PK, Kim K, Kang GH, et al. GPR50 promotes hepatocellular carcinoma progression via the notch signaling pathway through direct interaction with ADAM17. Mol Ther Oncolytics. 2020;17:332\u201349. https:\/\/doi.org\/10.1016\/j.omto.2020.04.002.","journal-title":"Mol Ther Oncolytics"},{"key":"2704_CR12","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/onc.2016.221","volume":"36","author":"SK Saha","year":"2017","unstructured":"Saha SK, Choi HY, Kim BW, Dayem AA, Yang GM, Kim KS, et al. 2017 KRT19 directly interacts with \u03b2-catenin\/RAC1 complex to regulate NUMB-dependent NOTCH signaling pathway and breast cancer properties. Oncogene. 2017;36:332\u201349. https:\/\/doi.org\/10.1038\/onc.2016.221.","journal-title":"Oncogene"},{"key":"2704_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10081292","author":"KM Lim","year":"2021","unstructured":"Lim KM, Dayem AA, Choi Y, Lee Y, An J, Gil M, et al. High therapeutic and esthetic properties of extracellular vesicles produced from the stem cells and their spheroids cultured from ocular surgery-derived waste orbicularis oculi muscle tissues. Antioxidants (Basel). 2021. https:\/\/doi.org\/10.3390\/antiox10081292.","journal-title":"Antioxidants (Basel)"},{"key":"2704_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11010099","author":"SK Saha","year":"2019","unstructured":"Saha SK, Yin Y, Chae HS, Opposing CSG. Regulation of cancer properties via KRT19-mediated differential modulation of Wnt\/\u03b2-catenin\/notch signaling in breast and colon cancers. Cancers (Basel). 2019. https:\/\/doi.org\/10.3390\/cancers11010099.","journal-title":"Cancers (Basel)"},{"key":"2704_CR15","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13058-018-1071-2","volume":"21","author":"HY Choi","year":"2019","unstructured":"Choi HY, Yang GM, Dayem AA, Saha SK, Kim K, Yoo Y, et al. Hydrodynamic shear stress promotes epithelial-mesenchymal transition by downregulating ERK and GSK3\u03b2 activities. Breast Cancer Res. 2019;21:6. https:\/\/doi.org\/10.1186\/s13058-018-1071-2.","journal-title":"Breast Cancer Res"},{"key":"2704_CR16","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1097\/cm9.0000000000002108","volume":"135","author":"C Xia","year":"2022","unstructured":"Xia C, Dong X, Li H, Cao M, Sun D, He S, et al. Cancer statistics in China and United States, 2022: profiles, trends, and determinants. Chin Med J. 2022;135:584\u201390. https:\/\/doi.org\/10.1097\/cm9.0000000000002108.","journal-title":"Chin Med J"},{"key":"2704_CR17","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1097\/mco.0000000000000381","volume":"20","author":"C Corbet","year":"2017","unstructured":"Corbet C, Feron O. Emerging roles of lipid metabolism in cancer progression. Curr Opin Clin Nutr Metab Care. 2017;20:254\u201360. https:\/\/doi.org\/10.1097\/mco.0000000000000381.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"2704_CR18","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s00262-016-1945-z","volume":"66","author":"R Pichler","year":"2017","unstructured":"Pichler R, Gruenbacher G, Culig Z, Brunner A, Fuchs D, Fritz J, et al. Intratumoral Th2 predisposition combines with an increased Th1 functional phenotype in clinical response to intravesical BCG in bladder cancer. Cancer Immunol Immunother. 2017;66:427\u201340. https:\/\/doi.org\/10.1007\/s00262-016-1945-z.","journal-title":"Cancer Immunol Immunother"},{"key":"2704_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14071681","author":"AC Pe\u00f1a-Romero","year":"2022","unstructured":"Pe\u00f1a-Romero AC, Orenes-Pi\u00f1ero E. Dual effect of immune cells within tumour microenvironment: pro- and anti-tumour effects and their triggers. Cancers (Basel). 2022. https:\/\/doi.org\/10.3390\/cancers14071681.","journal-title":"Cancers (Basel)"},{"key":"2704_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13153772","author":"A Dou","year":"2021","unstructured":"Dou A, Fang J. Heterogeneous myeloid cells in tumors. Cancers (Basel). 2021. https:\/\/doi.org\/10.3390\/cancers13153772.","journal-title":"Cancers (Basel)"},{"key":"2704_CR21","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","volume":"22","author":"A Glaviano","year":"2023","unstructured":"Glaviano A, Foo ASC, Lam HY, Yap KCH, Jacot W, Jones RH, et al. PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer. Mol Cancer. 2023;22:138. https:\/\/doi.org\/10.1186\/s12943-023-01827-6.","journal-title":"Mol Cancer"},{"key":"2704_CR22","doi-asserted-by":"publisher","first-page":"37","DOI":"10.31083\/j.fbl2802037","volume":"28","author":"J Zhong","year":"2023","unstructured":"Zhong J, Ding S, Zhang X, Di W, Wang X, Zhang H, et al. To investigate the occurrence and development of colorectal cancer based on the PI3K\/AKT\/mTOR signaling pathway. Front Biosci. 2023;28:37. https:\/\/doi.org\/10.31083\/j.fbl2802037.","journal-title":"Front Biosci"},{"key":"2704_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/cells12070990","author":"W Groenewald","year":"2023","unstructured":"Groenewald W, Lund AH, Gay DM. The role of WNT pathway mutations in cancer development and an overview of therapeutic options. Cells. 2023. https:\/\/doi.org\/10.3390\/cells12070990.","journal-title":"Cells"},{"key":"2704_CR24","first-page":"238","volume":"30","author":"Z Li","year":"2024","unstructured":"Li Z, Wu S, Liu W. Advances of Wnt\/\u03b2-catenin signaling pathway in lung cancer: A review. Altern Ther Health Med. 2024;30:238\u201347.","journal-title":"Altern Ther Health Med"},{"key":"2704_CR25","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1158\/1078-0432.Ccr-19-2230","volume":"26","author":"K Kobatake","year":"2020","unstructured":"Kobatake K, Ikeda KI, Nakata Y, Yamasaki N, Ueda T, Kanai A, et al. Kdm6a deficiency activates inflammatory pathways, promotes M2 macrophage polarization, and causes bladder cancer in cooperation with p53 dysfunction. Clin Cancer Res. 2020;26:2065\u201379. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-19-2230.","journal-title":"Clin Cancer Res"},{"key":"2704_CR26","doi-asserted-by":"publisher","first-page":"e140923221042","DOI":"10.2174\/1874467217666230914090621","volume":"17","author":"DV Lim","year":"2024","unstructured":"Lim DV, Woo WH, Lim JX, Loh XY, Soh HT, Lim SYA, et al. Targeting mutant-p53 for cancer treatment: are we there yet? Curr Mol Pharmacol. 2024;17:e140923221042. https:\/\/doi.org\/10.2174\/1874467217666230914090621.","journal-title":"Curr Mol Pharmacol"},{"key":"2704_CR27","doi-asserted-by":"publisher","first-page":"104","DOI":"10.7150\/thno.30308","volume":"9","author":"K Zheng","year":"2019","unstructured":"Zheng K, He Z, Kitazato K, Wang Y. Selective autophagy regulates cell cycle in cancer therapy. Theranostics. 2019;9:104\u201325. https:\/\/doi.org\/10.7150\/thno.30308.","journal-title":"Theranostics"},{"key":"2704_CR28","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.1200\/jco.2016.69.0032","volume":"35","author":"M Ingham","year":"2017","unstructured":"Ingham M, Schwartz GK. Cell-cycle therapeutics come of age. J Clin Oncol. 2017;35:2949\u201359. https:\/\/doi.org\/10.1200\/jco.2016.69.0032.","journal-title":"J Clin Oncol"},{"key":"2704_CR29","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41392-023-01347-1","volume":"8","author":"H Wang","year":"2023","unstructured":"Wang H, Guo M, Wei H, Chen Y. Targeting p53 pathways: mechanisms, structures, and advances in therapy. Signal Transduct Target Ther. 2023;8:92. https:\/\/doi.org\/10.1038\/s41392-023-01347-1.","journal-title":"Signal Transduct Target Ther"},{"key":"2704_CR30","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.molcel.2016.02.019","volume":"61","author":"PD Bhola","year":"2016","unstructured":"Bhola PD, Letai A. Mitochondria-judges and executioners of cell death sentences. Mol Cell. 2016;61:695\u2013704. https:\/\/doi.org\/10.1016\/j.molcel.2016.02.019.","journal-title":"Mol Cell"},{"issue":"3","key":"2704_CR31","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1111\/febs.14186","volume":"285","author":"A Pe\u00f1a-Blanco","year":"2018","unstructured":"Pe\u00f1a-Blanco A, Garc\u00eda-S\u00e1ez AJ. Bax, Bak and beyond\u2014mitochondrial performance in apoptosis. FEBS J. 2018;285(3):416\u201331.","journal-title":"FEBS J"},{"key":"2704_CR32","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/s0092-8674(00)80434-1","volume":"91","author":"P Li","year":"1997","unstructured":"Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, et al. Cytochrome c and dATP-dependent formation of Apaf-1\/caspase-9 complex initiates an apoptotic protease cascade. Cell. 1997;91:479\u201389. https:\/\/doi.org\/10.1016\/s0092-8674(00)80434-1.","journal-title":"Cell"},{"key":"2704_CR33","doi-asserted-by":"publisher","first-page":"97","DOI":"10.4103\/ijp.ijp_168_22","volume":"55","author":"Y Lan","year":"2023","unstructured":"Lan Y, Yang Y, Das A, Bhattacharya B, Roy S. Raptinal ameliorates 1,2-dimethylhydrazine-induced colon cancer through p53\/Bcl2\/Bax\/caspase-3-mediated apoptotic events in vitro and in vivo. Indian J Pharmacol. 2023;55:97\u2013107. https:\/\/doi.org\/10.4103\/ijp.ijp_168_22.","journal-title":"Indian J Pharmacol"},{"key":"2704_CR34","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1038\/sj.cdd.4401962","volume":"13","author":"MT Hemann","year":"2006","unstructured":"Hemann MT, Lowe SW. The p53-Bcl-2 connection. Cell Death Differ. 2006;13:1256\u20139. https:\/\/doi.org\/10.1038\/sj.cdd.4401962.","journal-title":"Cell Death Differ"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-02704-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-025-02704-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-02704-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T01:57:18Z","timestamp":1746151038000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-025-02704-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,9]]},"references-count":34,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["2704"],"URL":"https:\/\/doi.org\/10.1007\/s12032-025-02704-6","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,9]]},"assertion":[{"value":"10 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there are no conflicts of interest in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study is approved and supervised by the by the Ethics Committee of Qingdao Municipal Hospital (KTLL202306070). This research complies with the 1964 Declaration of Helsinki and its subsequent amendments or similar ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent for this study was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"156"}}